Abstract
- Ethiopia faces growing demand for new vaccines while donor support declines, making evidence-based prioritization crucial.
- The ENITAG applied MCDA tool (NVI-PST), adapted to the national context, to rank six candidate vaccines for 2026–2030.
- Hexavalent and rubella vaccines emerged as top priorities while RSV and MMCV as medium priorities for routine introduction.
- Recommendations factored in vaccines in the pipeline, health system constraints, and the need for stronger data systems.
- It marks a shift to strategic, transparent, and replicable decision-making in Ethiopia's EPI, offering a model for other LIC.
Recommendation
Africa
Ethiopia
